Crescent Biopharma, Inc. · NASDAQ:CBIO

Fairmount Funds Management LLC reported a 19.99% stake in Crescent Biopharma, Inc. (Schedule 13D)

Event Jun 13, 2025 · Filed Jun 23, 2025

Fairmount Funds Management LLC reported a 19.99% stake in Crescent Biopharma, Inc., 3,124,220 shares, with active intent on Jun 13, 2025. Filed Jun 23, 2025 (Schedule 13D).

Stake
19.99%
Shares
3,124,220
Intent
Active
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Fairmount Funds Management LLC19.99%3,124,220
Fairmount Healthcare Fund II L.P.19.99%3,124,220
Peter Evan Harwin19.99%3,124,220
Tomas Kiselak19.99%3,124,220

Source

View original at SEC

Related